Company intelligence / Profile preview
Luna Bioscience
Westport, Connecticut, United Stateslunabioscienceinc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Luna Bioscience has identified novel antigens that mediate vaccine protection from leptospira. Proof-of-principle has been demonstrated in two animal models. Dog safety and immunogenicity trials are complete; the company is preparing for pivotal dog studies and an IND submission for a Phase 1 human clinical trial. The company also integrates diagnostic tests with its vaccines as part of its product offering.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineDiagnostic test
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Seeking strategic partners and funding
Beyond the preview
Go deeper on Luna Bioscience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Luna Bioscience.